In Vitro Model Systems for the Study of Hormone-Dependent Human Breast Cancer

Howard L. Bleich, Emily S. Boro, Marc E. Lippman, C. Kent Osborne, Richard Knazek, Nathaniel Young

Research output: Contribution to journalReview articlepeer-review

80 Scopus citations


The hormone-dependent nature of some human breast cancers has been appreciated since the pioneering work of Beatson more than 75 years ago.1 Since then, a variety of ablative and additive therapies have been used to induce clinically important palliations in patients with metastatic breast cancer. Such tumor regressions have also been duplicated in several animal-model systems — notably, in rats with dimethylbenz(a)anthracene-induced mammary cancer.2 Nonetheless, the data accumulated in clinical and animal studies have failed to define the mechanisms whereby adrenalectomy, hypophysectomy or treatment with androgens, estrogens, progestins or glucocorticoids leads to tumor regression in some patients. In vivo studies.

Original languageEnglish (US)
Pages (from-to)154-159
Number of pages6
JournalNew England Journal of Medicine
Issue number3
StatePublished - Jan 20 1977

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'In Vitro Model Systems for the Study of Hormone-Dependent Human Breast Cancer'. Together they form a unique fingerprint.

Cite this